OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The genetic landscape of metaplastic breast cancers and uterine carcinosarcomas
Lea A. Moukarzel, Lorenzo Ferrando, Arnaud Da Cruz Paula, et al.
Molecular Oncology (2020) Vol. 15, Iss. 4, pp. 1024-1039
Open Access | Times Cited: 32
Lea A. Moukarzel, Lorenzo Ferrando, Arnaud Da Cruz Paula, et al.
Molecular Oncology (2020) Vol. 15, Iss. 4, pp. 1024-1039
Open Access | Times Cited: 32
Showing 1-25 of 32 citing articles:
Ovarian cancer mutational processes drive site-specific immune evasion
Ignacio Vázquez-Garćıa, Florian Uhlitz, Nicholas Ceglia, et al.
Nature (2022) Vol. 612, Iss. 7941, pp. 778-786
Open Access | Times Cited: 155
Ignacio Vázquez-Garćıa, Florian Uhlitz, Nicholas Ceglia, et al.
Nature (2022) Vol. 612, Iss. 7941, pp. 778-786
Open Access | Times Cited: 155
Uterine carcinosarcoma: Contemporary clinical summary, molecular updates, and future research opportunity
Shinya Matsuzaki, Maximilian Klar, Satoko Matsuzaki, et al.
Gynecologic Oncology (2020) Vol. 160, Iss. 2, pp. 586-601
Closed Access | Times Cited: 89
Shinya Matsuzaki, Maximilian Klar, Satoko Matsuzaki, et al.
Gynecologic Oncology (2020) Vol. 160, Iss. 2, pp. 586-601
Closed Access | Times Cited: 89
Nivolumab for mismatch-repair-deficient or hypermutated gynecologic cancers: a phase 2 trial with biomarker analyses
Claire F. Friedman, Beryl Manning‐Geist, Qin Zhou, et al.
Nature Medicine (2024) Vol. 30, Iss. 5, pp. 1330-1338
Open Access | Times Cited: 8
Claire F. Friedman, Beryl Manning‐Geist, Qin Zhou, et al.
Nature Medicine (2024) Vol. 30, Iss. 5, pp. 1330-1338
Open Access | Times Cited: 8
A comprehensive overview of metaplastic breast cancer: Features and treatments
Qiaoke Yan, Yuwei Deng, Qingyuan Zhang
Cancer Science (2024) Vol. 115, Iss. 8, pp. 2506-2514
Open Access | Times Cited: 6
Qiaoke Yan, Yuwei Deng, Qingyuan Zhang
Cancer Science (2024) Vol. 115, Iss. 8, pp. 2506-2514
Open Access | Times Cited: 6
Uterine carcinosarcoma: An overview
Gaetano Pezzicoli, Francesca Moscaritolo, Erica Silvestris, et al.
Critical Reviews in Oncology/Hematology (2021) Vol. 163, pp. 103369-103369
Closed Access | Times Cited: 39
Gaetano Pezzicoli, Francesca Moscaritolo, Erica Silvestris, et al.
Critical Reviews in Oncology/Hematology (2021) Vol. 163, pp. 103369-103369
Closed Access | Times Cited: 39
Metaplastic Breast Cancer: Current Understanding and Future Directions
Alexandra Thomas, Emily Douglas, Jorge S. Reis‐Filho, et al.
Clinical Breast Cancer (2023) Vol. 23, Iss. 8, pp. 775-783
Closed Access | Times Cited: 15
Alexandra Thomas, Emily Douglas, Jorge S. Reis‐Filho, et al.
Clinical Breast Cancer (2023) Vol. 23, Iss. 8, pp. 775-783
Closed Access | Times Cited: 15
Metaplastic breast cancer: an all-round multidisciplinary consensus
Giovanni Corso, Carmen Criscitiello, Luca Nicosia, et al.
European Journal of Cancer Prevention (2023)
Open Access | Times Cited: 11
Giovanni Corso, Carmen Criscitiello, Luca Nicosia, et al.
European Journal of Cancer Prevention (2023)
Open Access | Times Cited: 11
Direct prediction of Homologous Recombination Deficiency from routine histology in ten different tumor types with attention-based Multiple Instance Learning: a development and validation study
Chiara Maria Lavinia Loeffler, Omar S.M. El Nahhas, Hannah Sophie Muti, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 10
Chiara Maria Lavinia Loeffler, Omar S.M. El Nahhas, Hannah Sophie Muti, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 10
The mixed subtype has a worse prognosis than other histological subtypes: a retrospective analysis of 217 patients with metaplastic breast cancer
Jiayue Hu, Ronggang Lang, Weipeng Zhao, et al.
Breast Cancer Research and Treatment (2023) Vol. 200, Iss. 1, pp. 23-36
Open Access | Times Cited: 10
Jiayue Hu, Ronggang Lang, Weipeng Zhao, et al.
Breast Cancer Research and Treatment (2023) Vol. 200, Iss. 1, pp. 23-36
Open Access | Times Cited: 10
Germline pathogenic variants in metaplastic breast cancer patients and the emerging role of the BRCA1 gene
Giovanni Corso, Monica Marabelli, Mariarosaria Calvello, et al.
European Journal of Human Genetics (2023) Vol. 31, Iss. 11, pp. 1275-1282
Open Access | Times Cited: 10
Giovanni Corso, Monica Marabelli, Mariarosaria Calvello, et al.
European Journal of Human Genetics (2023) Vol. 31, Iss. 11, pp. 1275-1282
Open Access | Times Cited: 10
Therapeutic strategies and landscape of metaplastic breast cancer
Peilin Dai, Tianyi Song, Junzhi Liu, et al.
Cancer Treatment Reviews (2025) Vol. 133, pp. 102885-102885
Closed Access
Peilin Dai, Tianyi Song, Junzhi Liu, et al.
Cancer Treatment Reviews (2025) Vol. 133, pp. 102885-102885
Closed Access
Pathogenic Germline Variants in Patients With Metaplastic Breast Cancer
Kaitlin Demarest, Arravinth Anantharajah, Kara N. Maxwell, et al.
JAMA Network Open (2025) Vol. 8, Iss. 2, pp. e2460312-e2460312
Open Access
Kaitlin Demarest, Arravinth Anantharajah, Kara N. Maxwell, et al.
JAMA Network Open (2025) Vol. 8, Iss. 2, pp. e2460312-e2460312
Open Access
Case Report: Lasting complete response to pembrolizumab in mismatch repair-deficient cardiac sarcoma: a genomic characterization
Daniela A. Ferraro, Bettina Bisig, David C. Rotzinger, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Daniela A. Ferraro, Bettina Bisig, David C. Rotzinger, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Predicting breast cancer-specific survival in metaplastic breast cancer patients using machine learning algorithms
Yufan Feng, Natasha McGuire, Alexandra Walton, et al.
Journal of Pathology Informatics (2023) Vol. 14, pp. 100329-100329
Open Access | Times Cited: 9
Yufan Feng, Natasha McGuire, Alexandra Walton, et al.
Journal of Pathology Informatics (2023) Vol. 14, pp. 100329-100329
Open Access | Times Cited: 9
Epithelial to mesenchymal transition (EMT) in metaplastic breast cancer and phyllodes breast tumors
Ιωάννα Ακρίδα, Francesk Mulita, Kerasia‐Maria Plachouri, et al.
Medical Oncology (2023) Vol. 41, Iss. 1
Closed Access | Times Cited: 9
Ιωάννα Ακρίδα, Francesk Mulita, Kerasia‐Maria Plachouri, et al.
Medical Oncology (2023) Vol. 41, Iss. 1
Closed Access | Times Cited: 9
Prediction of homologous recombination deficiency from routine histology with attention-based multiple instance learning in nine different tumor types
Chiara Maria Lavinia Loeffler, Omar S.M. El Nahhas, Hannah Sophie Muti, et al.
BMC Biology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 3
Chiara Maria Lavinia Loeffler, Omar S.M. El Nahhas, Hannah Sophie Muti, et al.
BMC Biology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 3
An Update on the Molecular Pathology of Metaplastic Breast Cancer
Amy E. McCart Reed, Emarene Kalaw, Sunil R. Lakhani
Breast Cancer Targets and Therapy (2021) Vol. Volume 13, pp. 161-170
Open Access | Times Cited: 19
Amy E. McCart Reed, Emarene Kalaw, Sunil R. Lakhani
Breast Cancer Targets and Therapy (2021) Vol. Volume 13, pp. 161-170
Open Access | Times Cited: 19
The Role of FBXW7 in Gynecologic Malignancies
Riccardo Di Fiore, Sherif Suleiman, Rosa Drago‐Ferrante, et al.
Cells (2023) Vol. 12, Iss. 10, pp. 1415-1415
Open Access | Times Cited: 7
Riccardo Di Fiore, Sherif Suleiman, Rosa Drago‐Ferrante, et al.
Cells (2023) Vol. 12, Iss. 10, pp. 1415-1415
Open Access | Times Cited: 7
Germline drivers of gynecologic carcinosarcomas
Tiffany Y. Sia, Sushmita Gordhandas, Özge Ceyhan-Birsoy, et al.
Gynecologic Oncology (2023) Vol. 174, pp. 34-41
Open Access | Times Cited: 7
Tiffany Y. Sia, Sushmita Gordhandas, Özge Ceyhan-Birsoy, et al.
Gynecologic Oncology (2023) Vol. 174, pp. 34-41
Open Access | Times Cited: 7
Epidemiology, site-specific characteristics and survival of carcinosarcoma: a retrospective study based on SEER database
Liansha Tang, Yuwen Zhou, Jialing Wang, et al.
BMJ Open (2023) Vol. 13, Iss. 12, pp. e077974-e077974
Open Access | Times Cited: 4
Liansha Tang, Yuwen Zhou, Jialing Wang, et al.
BMJ Open (2023) Vol. 13, Iss. 12, pp. e077974-e077974
Open Access | Times Cited: 4
Metaplastic breast cancers and triple-negative breast cancers of no special type: are they prognostically different? A systematic review and meta-analysis
Giovanni Corso, Oriana D’Ecclesiis, Francesca Magnoni, et al.
European Journal of Cancer Prevention (2021) Vol. 31, Iss. 5, pp. 459-466
Closed Access | Times Cited: 8
Giovanni Corso, Oriana D’Ecclesiis, Francesca Magnoni, et al.
European Journal of Cancer Prevention (2021) Vol. 31, Iss. 5, pp. 459-466
Closed Access | Times Cited: 8
Immune and malignant cell phenotypes of ovarian cancer are determined by distinct mutational processes
Ignacio Vázquez-Garćıa, Florian Uhlitz, Nicholas Ceglia, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 6
Ignacio Vázquez-Garćıa, Florian Uhlitz, Nicholas Ceglia, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 6
Ovarian carcinosarcomas: p53 status defines two distinct patterns of oncogenesis and outcomes
Gurdial Dhillon, Marta Llaurado-Fernandez, Basile Tessier‐Cloutier, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access
Gurdial Dhillon, Marta Llaurado-Fernandez, Basile Tessier‐Cloutier, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access
HER2-Positive Serous Endometrial Cancer Treatment: Current Clinical Practice and Future Directions
Dimitrios Papageorgiou, Galateia Liouta, Ioakeim Sapantzoglou, et al.
Medicina (2024) Vol. 60, Iss. 12, pp. 2012-2012
Open Access
Dimitrios Papageorgiou, Galateia Liouta, Ioakeim Sapantzoglou, et al.
Medicina (2024) Vol. 60, Iss. 12, pp. 2012-2012
Open Access
Comprehensive Study of Human FBXW7 Deleterious nsSNP’s Functional Inference and Susceptibility to Gynaecological Cancer
K. Vasuki, Jemmy Christy
Applied Biochemistry and Biotechnology (2021) Vol. 194, Iss. 1, pp. 407-433
Closed Access | Times Cited: 3
K. Vasuki, Jemmy Christy
Applied Biochemistry and Biotechnology (2021) Vol. 194, Iss. 1, pp. 407-433
Closed Access | Times Cited: 3
